Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma
Stopped early · Phase 2
Conditions studied: Melanoma (Skin)
In brief
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether giving paclitaxel together with carboplatin is more effective than giving temozolomide alone in treating patients with melanoma. PURPOSE: This phase II trial is studying the side effects and how well giving paclitaxel together with carboplatin or giving temozolomide alone works in treating patients with stage IV melanoma.
Key facts
- Study ID
- NCT00568451
- Run by
- Mayo Clinic
- People needed
- 12
- Starts
- 2006-06-01
- Expected to finish
- 2012-04-01
- Last updated by the study team
- 2015-12-30
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic Cancer Center — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.